13 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

POLYMER COATED POWDER FREE NITRILE EXAMINATION GLOVES (BLUE,WHITE,VIOLET, PINK,GREEN)

FDA 510(k)
FDA Class 1 ·General Hospital

Medline Industries, Inc.

FDA UDI
MEDLINE INDUSTRIES, INC.·10080196983902·HYPERINFLATION SYSTEM

Implant-One

FDA UDI
Implant Logistics, Inc.·D762APT0505300·Abutment, 500 Series Angled Post .5mm Cuff Heig...

BELLEGLASS HP ENAMEL

FDA 510(k)
FDA Class 2 ·Dental

GEO STRUCTURE

FDA 510(k)
FDA Class 2 ·Orthopedic

Widex

FDA UDI
Widex A/S·05706069687118·Widex EVOKE E-IM (Clay brown ) 330, Left

Widex

FDA UDI
Widex A/S·05706069687125·Widex EVOKE E-IM (Dark brown ) 330, Left

Widex

FDA UDI
Widex A/S·05706069687101·Widex EVOKE E-IM (Light beige ) 330, Left

COSYCOT INFANT WARMER

FDA Adverse Event
Malfunction ·FISHER & PAYKEL HEALTHCARE, LTD.·Product code FMT·May 5, 2008

ITRAK 3500

FDA Adverse Event
Malfunction ·GE OEC MEDICAL SYSTEMS(SLC)·Product code LLZ·April 8, 2013

HEARTSTART MRX - EMS DEFIBRILLATOR

FDA Adverse Event
Malfunction ·PHILIPS HEALTHCARE·Product code MKJ·April 5, 2011

TENDRIL SDX

FDA Adverse Event
Injury ·ST JUDE MEDICAL CARDIAC RHYTHM MANAGEMENT DIVISION·Product code DTB·May 27, 2008

Boston Scientific COGNIS CRT-D, Cardiac Resynchronization Therapy Defibrillator, models N118, N119. The following models are not available in the US: models N106, N107, P106, P107. Sterilized using ethylene oxide. Product Usage: Boston Scientific cardiac resynchronization therapy defibrillators (CRT-Ds) are indicated for patients with moderate to severe heart failure who remain symptomatic despite stable, optimal heart failure drug therapy and have left ventricular dysfunction and QRS duration > or equal to 120 ms. This family of pulse generators provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Cardiac Resynchronization Therapy (CRT), which treats heart failure by resynchronizing ventricular contractions through biventricular electrical stimulation; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy.

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014